Zida

Zida is a private health technology and medical device company commercializing a home-use wearable neuromodulation system for bladder control disorders. Its lead product, the Zida Control Sock, is an FDA-cleared Class II device that delivers transcutaneous tibial nerve stimulation through embedded electrodes in a wearable garment connected to a control unit. The company focuses on overactive bladder and related symptoms including urinary urgency, urinary frequency, urge incontinence, and nocturia. Zida markets its system as a prescription device for at-home treatment and reimbursement through Medicare, the VA, and private insurers. The business appears centered on commercialization of a single lead urology device rather than a broad drug pipeline.